TreeWAS – Variant ID: rs765855

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I77.1 Stricture of artery	0.044	0.956	0.000
I77.9 Disorder of arteries and arterioles, unspecified	0.042	0.958	0.000
I77 Other disorders of arteries and arterioles	0.042	0.958	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.042	0.958	0.000
I77.6 Arteritis, unspecified	0.036	0.964	0.000
I77.0 Arteriovenous fistula, acquired	0.034	0.966	0.000
I77.3 Arterial fibromuscular dysplasia	0.033	0.967	0.000
R51 Headache	0.000	0.967	0.033
I77.5 Necrosis of artery	0.030	0.969	0.000
I77.4 Coeliac artery compression syndrome	0.030	0.969	0.000
I77.2 Rupture of artery	0.027	0.972	0.000
I77.8 Other specified disorders of arteries and arterioles	0.027	0.973	0.000
I67.9 Cerebrovascular disease, unspecified	0.023	0.977	0.000
C80.9 Malignant neoplasm, unspecified	0.020	0.980	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.020	0.980	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.017	0.983	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.017	0.983	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.017	0.983	0.000
C80 Malignant neoplasm without specification of site	0.017	0.983	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.015	0.985	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.015	0.985	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.015	0.985	0.000
C80.0 Malignant neoplasm, primary site unknown, so stated	0.015	0.985	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.015	0.985	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.014	0.986	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.014	0.986	0.000
C15.5 Lower third of oesophagus	0.014	0.986	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.013	0.987	0.000
T46.1 Calcium-channel blockers	0.013	0.987	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.013	0.987	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.013	0.987	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.013	0.987	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.013	0.987	0.000
C79 Secondary malignant neoplasm of other sites	0.012	0.988	0.000
T39.4 Antirheumatics, not elsewhere classified	0.012	0.988	0.000
T39.2 Pyrazolone derivatives	0.012	0.988	0.000
T43.9 Psychotropic drug, unspecified	0.012	0.988	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.012	0.988	0.000
C15 Malignant neoplasm of oesophagus	0.012	0.988	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.012	0.988	0.000
T39.0 Salicylates	0.012	0.988	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.012	0.988	0.000
C15.3 Upper third of oesophagus	0.011	0.989	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.011	0.989	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.011	0.989	0.000
T46.7 Peripheral vasodilators	0.011	0.989	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.011	0.989	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.011	0.989	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.011	0.989	0.000
T36 Poisoning by systemic antibiotics	0.011	0.989	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.011	0.989	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.011	0.989	0.000
C15.4 Middle third of oesophagus	0.011	0.989	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.011	0.989	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.011	0.989	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.010	0.989	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.011	0.989	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.010	0.990	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.010	0.990	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.010	0.990	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.010	0.990	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.010	0.990	0.000
T43.6 Psychostimulants with abuse potential	0.010	0.990	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.010	0.990	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.010	0.990	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.010	0.990	0.000
C15.1 Thoracic part of oesophagus	0.009	0.990	0.000
C15.0 Cervical part of oesophagus	0.009	0.991	0.000
T50.7 Analeptics and opioid receptor antagonists	0.009	0.991	0.000
T50.5 Appetite depressants	0.009	0.991	0.000
T50.4 Drugs affecting uric acid metabolism	0.009	0.991	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.009	0.991	0.000
T50.0 Mineralocorticoids and their antagonists	0.009	0.991	0.000
D59.1 Other autoimmune haemolytic anaemias	0.000	0.991	0.009
C15.9 Oesophagus, unspecified	0.009	0.991	0.000
C15.8 Overlapping lesion of oesophagus	0.009	0.991	0.000
C15.2 Abdominal part of oesophagus	0.009	0.991	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.009	0.991	0.000
T40.6 Other and unspecified narcotics	0.009	0.991	0.000
C79.2 Secondary malignant neoplasm of skin	0.009	0.991	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.009	0.991	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.009	0.991	0.000
T50.8 Diagnostic agents	0.008	0.991	0.000
T45.0 Antiallergic and antiemetic drugs	0.008	0.991	0.000
T36.0 Penicillins	0.008	0.992	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.008	0.992	0.000
T43.2 Other and unspecified antidepressants	0.008	0.992	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.008	0.992	0.000
C34.9 Bronchus or lung, unspecified	0.008	0.992	0.000
C76.3 Pelvis	0.008	0.992	0.000
T41.5 Therapeutic gases	0.008	0.992	0.000
T41.4 Anaesthetic, unspecified	0.008	0.992	0.000
T41.3 Local anaesthetics	0.008	0.992	0.000
T41.2 Other and unspecified general anaesthetics	0.008	0.992	0.000
T41.1 Intravenous anaesthetics	0.008	0.992	0.000
T41.0 Inhaled anaesthetics	0.008	0.992	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.008	0.992	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.008	0.992	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.008	0.992	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.008	0.992	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.008	0.992	0.000
T44.0 Anticholinesterase agents	0.008	0.992	0.000
T36.9 Systemic antibiotic, unspecified	0.008	0.992	0.000
T36.7 Antifungal antibiotics, systemically used	0.008	0.992	0.000
T36.6 Rifamycins	0.008	0.992	0.000
T36.5 Aminoglycosides	0.008	0.992	0.000
T36.2 Chloramphenicol group	0.008	0.992	0.000
I74 Arterial embolism and thrombosis	0.008	0.992	0.000
T49.9 Topical agent, unspecified	0.008	0.992	0.000
T49.8 Other topical agents	0.008	0.992	0.000
T49.7 Dental drugs, topically applied	0.008	0.992	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.008	0.992	0.000
T49.5 Ophthalmological drugs and preparations	0.008	0.992	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.008	0.992	0.000
T49.3 Emollients, demulcents and protectants	0.008	0.992	0.000
T49.2 Local astringents and local detergents	0.008	0.992	0.000
T49.1 Antipruritics	0.008	0.992	0.000
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.008	0.992	0.000
T50.1 Loop [high-ceiling] diuretics	0.008	0.992	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.008	0.992	0.000
T48.4 Expectorants	0.008	0.992	0.000
T48.3 Antitussives	0.008	0.992	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.008	0.992	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.008	0.992	0.000
T48.0 Oxytocic drugs	0.008	0.992	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.008	0.992	0.000
T47.0 Histamine H(2)-receptor antagonists	0.008	0.992	0.000
T36.8 Other systemic antibiotics	0.008	0.992	0.000
T36.3 Macrolides	0.008	0.992	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.008	0.992	0.000
C76.2 Abdomen	0.008	0.992	0.000
Z86.1 Personal history of infectious and parasitic diseases	0.000	0.992	0.008
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.008	0.992	0.000
T40.1 Heroin	0.008	0.992	0.000
T40.5 Cocaine	0.008	0.992	0.000
D59 Acquired haemolytic anaemia	0.000	0.992	0.008
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.007	0.992	0.000
T37.5 Antiviral drugs	0.007	0.992	0.000
T37.4 Anthelminthics	0.007	0.992	0.000
T37.3 Other antiprotozoal drugs	0.007	0.992	0.000
T37.1 Antimycobacterial drugs	0.007	0.992	0.000
T37.0 Sulphonamides	0.007	0.992	0.000
T36.4 Tetracyclines	0.007	0.992	0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.008	0.992	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.007	0.992	0.000
T40.8 Lysergide [LSD]	0.007	0.992	0.000
T40.7 Cannabis (derivatives)	0.007	0.992	0.000
T40.0 Opium	0.007	0.992	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.007	0.993	0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.007	0.993	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.007	0.993	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.007	0.993	0.000
T40.4 Other synthetic narcotics	0.007	0.993	0.000
Y84.6 Urinary catheterisation	0.000	0.993	0.007
T38.9 Other and unspecified hormone antagonists	0.007	0.993	0.000
T38.7 Androgens and anabolic congeners	0.007	0.993	0.000
T38.4 Oral contraceptives	0.007	0.993	0.000
T38.2 Antithyroid drugs	0.007	0.993	0.000
T48.5 Anti-common-cold drugs	0.007	0.993	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.007	0.993	0.000
T45.8 Other primarily systemic and haematological agents	0.007	0.993	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.007	0.993	0.000
T45.6 Fibrinolysis-affecting drugs	0.007	0.993	0.000
T45.4 Iron and its compounds	0.007	0.993	0.000
T45.3 Enzymes, not elsewhere classified	0.007	0.993	0.000
T38.1 Thyroid hormones and substitutes	0.007	0.993	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.007	0.993	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.007	0.993	0.000
T47.7 Emetics	0.007	0.993	0.000
T47.5 Digestants	0.007	0.993	0.000
T47.3 Saline and osmotic laxatives	0.007	0.993	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.007	0.993	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.007	0.993	0.000
T40.3 Methadone	0.007	0.993	0.000
I74.8 Embolism and thrombosis of other arteries	0.007	0.993	0.000
T47.2 Stimulant laxatives	0.007	0.993	0.000
T38.5 Other oestrogens and progestogens	0.007	0.993	0.000
T45.2 Vitamins, not elsewhere classified	0.007	0.993	0.000
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.007	0.993	0.000
I74.0 Embolism and thrombosis of abdominal aorta	0.007	0.993	0.000
T38.0 Glucocorticoids and synthetic analogues	0.007	0.993	0.000
D59.0 Drug-induced autoimmune haemolytic anaemia	0.000	0.993	0.007
I70-I79 Diseases of arteries, arterioles and capillaries	0.007	0.993	0.000
D59.9 Acquired haemolytic anaemia, unspecified	0.000	0.993	0.007
C76.8 Overlapping lesion of other and ill-defined sites	0.006	0.993	0.000
C76.7 Other ill-defined sites	0.006	0.993	0.000
C76.5 Lower limb	0.006	0.993	0.000
C76.4 Upper limb	0.006	0.993	0.000
T47.6 Antidiarrhoeal drugs	0.006	0.993	0.000
I74.5 Embolism and thrombosis of iliac artery	0.007	0.993	0.000
T47.4 Other laxatives	0.006	0.994	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.006	0.994	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.006	0.994	0.000
C76.1 Thorax	0.006	0.994	0.000
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.006	0.994	0.000
D59.4 Other nonautoimmune haemolytic anaemias	0.000	0.994	0.006
T45.5 Anticoagulants	0.006	0.994	0.000
I70 Atherosclerosis	0.006	0.994	0.000
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.006	0.994	0.000
D59.8 Other acquired haemolytic anaemias	0.000	0.994	0.006
D59.6 Haemoglobinuria due to haemolysis from other external causes	0.000	0.994	0.006
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]	0.000	0.994	0.006
D59.3 Haemolytic-uraemic syndrome	0.000	0.994	0.006
D59.2 Drug-induced nonautoimmune haemolytic anaemia	0.000	0.994	0.006
I74.9 Embolism and thrombosis of unspecified artery	0.006	0.994	0.000
T39.1 4-Aminophenol derivatives	0.006	0.994	0.000
C79.6 Secondary malignant neoplasm of ovary	0.005	0.995	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.005	0.995	0.000
M19.1 Posttraumatic arthrosis of other joints	0.005	0.995	0.000
I70.2 Atherosclerosis of arteries of the extremities	0.005	0.995	0.000
I70.0 Atherosclerosis of aorta	0.005	0.995	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.005	0.995	0.000
I70.1 Atherosclerosis of renal artery	0.005	0.995	0.000
H66.3 Other chronic suppurative otitis media	0.000	0.995	0.005
M19.13 Post-traumatic arthrosis of other joints (Forearm)	0.005	0.995	0.000
C77.9 Lymph node, unspecified	0.005	0.995	0.000
Y84.4 Aspiration of fluid	0.000	0.995	0.005
H55 Nystagmus and other irregular eye movements	0.005	0.995	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.004	0.996	0.000
T40.2 Other opioids	0.004	0.996	0.000
D68.9 Coagulation defect, unspecified	0.004	0.996	0.000
I70.9 Generalised and unspecified atherosclerosis	0.004	0.996	0.000
I70.8 Atherosclerosis of other arteries	0.004	0.996	0.000
M19.16 Post-traumatic arthrosis of other joints-Lower leg	0.004	0.996	0.000
I70.00 Atherosclerosis of aorta (without gangrene)	0.004	0.996	0.000
M19.14 Post-traumatic arthrosis of other joints (Hand)	0.004	0.996	0.000
C76.0 Head, face and neck	0.004	0.996	0.001
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.004	0.996	0.000
M19.12 Post-traumatic arthrosis of other joints (Upper arm)	0.004	0.996	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
M23.21 Derangement of meniscus due to old tear or injury (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.004	0.996	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.004	0.996	0.000
M19.19 Post-traumatic arthrosis of other joints (Site unspecified)	0.004	0.996	0.000
M19.18 Post-traumatic arthrosis of other joints (Other)	0.004	0.996	0.000
M19.15 Post-traumatic arthrosis of other joints (Pelvic region and thigh)	0.004	0.996	0.000
M19.10 Post-traumatic arthrosis of other joints (Multiple sites)	0.004	0.996	0.000
Z82.7 Family history of congenital malformations, deformations and chromosomal abnormalities	0.000	0.996	0.004
I70.10 Atherosclerosis of renal artery (without gangrene)	0.004	0.996	0.000
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.004	0.996	0.000
D22.7 Melanocytic naevi of lower limb, including hip	0.000	0.996	0.004
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.004	0.996	0.000
I70.01 Atherosclerosis of aorta (with gangrene)	0.004	0.996	0.000
D55-D59 Haemolytic anaemias	0.000	0.996	0.004
I70.11 Atherosclerosis of renal artery (with gangrene)	0.003	0.996	0.000
I67.2 Cerebral atherosclerosis	0.004	0.996	0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.004	0.996	0.000
C73 Malignant neoplasm of thyroid gland	0.000	0.996	0.004
V23.4 Driver injured in traffic accident	0.000	0.996	0.004
M19.11 Post-traumatic arthrosis of other joints (Shoulder region)	0.003	0.996	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.996	0.000
C21.0 Anus, unspecified	0.003	0.996	0.000
C77.8 Lymph nodes of multiple regions	0.003	0.997	0.000
D58 Other hereditary haemolytic anaemias	0.000	0.997	0.003
I67 Other cerebrovascular diseases	0.003	0.997	0.000
I70.91 Generalized and unspecified atherosclerosis (with gangrene)	0.003	0.997	0.000
I70.81 Atherosclerosis of other arteries (with gangrene)	0.003	0.997	0.000
C77.1 Intrathoracic lymph nodes	0.003	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.003	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.003	0.997	0.000
I70.90 Generalized and unspecified atherosclerosis (without gangrene)	0.003	0.997	0.000
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.000	0.997	0.003
I70.80 Atherosclerosis of other arteries (without gangrene)	0.003	0.997	0.000
I73 Other peripheral vascular diseases	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.003	0.997	0.000
T42.3 Barbiturates	0.003	0.997	0.000
I67.4 Hypertensive encephalopathy	0.003	0.997	0.000
D58.9 Hereditary haemolytic anaemia, unspecified	0.000	0.997	0.003
G70.0 Myasthenia gravis	0.000	0.997	0.003
I79.1 Aortitis in diseases classified elsewhere	0.003	0.997	0.000
I79.0 Aneurysm of aorta in diseases classified elsewhere	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
G61.8 Other inflammatory polyneuropathies	0.000	0.997	0.003
I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.003	0.997	0.000
C21 Malignant neoplasm of anus and anal canal	0.003	0.997	0.000
D55 Anaemia due to enzyme disorders	0.000	0.997	0.003
C34 Malignant neoplasm of bronchus and lung	0.003	0.997	0.000
D58.0 Hereditary spherocytosis	0.000	0.997	0.003
D58.2 Other haemoglobinopathies	0.000	0.997	0.003
D57 Sickle-cell disorders	0.000	0.997	0.003
C23 Malignant neoplasm of gallbladder	0.003	0.997	0.000
I67.5 Moyamoya disease	0.003	0.997	0.000
I67.3 Progressive vascular leukoencephalopathy	0.003	0.997	0.000
D56 Thalassaemia	0.000	0.997	0.003
D58.8 Other specified hereditary haemolytic anaemias	0.000	0.997	0.003
D58.1 Hereditary elliptocytosis	0.000	0.997	0.003
M77.47 Metatarsalgia-Ankle/Foot	0.003	0.997	0.000
C71.3 Parietal lobe	0.003	0.997	0.000
R40.2 Coma, unspecified	0.003	0.997	0.000
C15-C26 Malignant neoplasms of digestive organs	0.003	0.997	0.000
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.002	0.997	0.000
Y84.7 Blood-sampling	0.000	0.997	0.002
Y84.5 Insertion of gastric or duodenal sound	0.000	0.997	0.002
I67.7 Cerebral arteritis, not elsewhere classified	0.002	0.997	0.000
I73.9 Peripheral vascular disease, unspecified	0.003	0.997	0.000
C21.1 Anal canal	0.003	0.997	0.000
C25.2 Tail of pancreas	0.003	0.997	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.000	0.997	0.003
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.997	0.003
C34.2 Middle lobe, bronchus or lung	0.002	0.997	0.000
Y84.9 Medical procedure, unspecified	0.000	0.997	0.002
T42.1 Iminostilbenes	0.002	0.997	0.000
I73.8 Other specified peripheral vascular diseases	0.002	0.998	0.000
I73.1 Thromboangiitis obliterans [Buerger]	0.002	0.998	0.000
G61.9 Inflammatory polyneuropathy, unspecified	0.000	0.998	0.002
Y84.2 Radiological procedure and radiotherapy	0.000	0.998	0.002
C21.2 Cloacogenic zone	0.002	0.998	0.000
H55-H59 Other disorders of eye and adnexa	0.002	0.998	0.000
S36.80 Injury of other intra-abdominal organs (without open wound into cavity)	0.000	0.998	0.002
D55.9 Anaemia due to enzyme disorder, unspecified	0.000	0.998	0.002
D55.8 Other anaemias due to enzyme disorders	0.000	0.998	0.002
D55.3 Anaemia due to disorders of nucleotide metabolism	0.000	0.998	0.002
D55.2 Anaemia due to disorders of glycolytic enzymes	0.000	0.998	0.002
D55.1 Anaemia due to other disorders of glutathione metabolism	0.000	0.998	0.002
D55.0 Anaemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency	0.000	0.998	0.002
D56.1 Beta thalassaemia	0.000	0.998	0.002
C25 Malignant neoplasm of pancreas	0.002	0.998	0.000
D39.1 Ovary	0.002	0.998	0.000
C71.7 Brain stem	0.002	0.998	0.000
X63.0 Home	0.002	0.998	0.000
C25.1 Body of pancreas	0.002	0.998	0.000
Y84.3 Shock therapy	0.000	0.998	0.002
G61 Inflammatory polyneuropathy	0.000	0.998	0.002
C34.8 Overlapping lesion of bronchus and lung	0.002	0.998	0.000
C71.9 Brain, unspecified	0.002	0.998	0.000
C71 Malignant neoplasm of brain	0.002	0.998	0.000
C71.1 Frontal lobe	0.002	0.998	0.000
S89.9 Unspecified injury of lower leg	0.002	0.998	0.000
C17.1 Jejunum	0.002	0.998	0.000
D57.8 Other sickle-cell disorders	0.000	0.998	0.002
D57.2 Double heterozygous sickling disorders	0.000	0.998	0.002
D57.0 Sickle-cell anaemia with crisis	0.000	0.998	0.002
I71 Aortic aneurysm and dissection	0.002	0.998	0.000
C17 Malignant neoplasm of small intestine	0.002	0.998	0.000
I78 Diseases of capillaries	0.002	0.998	0.000
D56.8 Other thalassaemias	0.000	0.998	0.002
D56.4 Hereditary persistence of foetal haemoglobin [HPFH]	0.000	0.998	0.002
D56.2 Delta-beta thalassaemia	0.000	0.998	0.002
D56.0 Alpha thalassaemia	0.000	0.998	0.002
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.000	0.998	0.002
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.000	0.998	0.002
L43.9 Lichen planus, unspecified	0.002	0.998	0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.002	0.998	0.000
C77.2 Intra-abdominal lymph nodes	0.002	0.998	0.000
D57.1 Sickle-cell anaemia without crisis	0.000	0.998	0.002
F32.2 Severe depressive episode without psychotic symptoms	0.002	0.998	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.002	0.998	0.000
T42.4 Benzodiazepines	0.002	0.998	0.000
C25.9 Pancreas, unspecified	0.002	0.998	0.000
G71.1 Myotonic disorders	0.002	0.998	0.000
C21.8 Overlapping lesion of rectum, anus and anal canal	0.002	0.998	0.000
D57.3 Sickle-cell trait	0.000	0.998	0.002
S83.6 Sprain and strain of other and unspecified parts of knee	0.002	0.998	0.000
V23 Motorcycle rider injured in collision with car, pick-up truck or van	0.000	0.998	0.002
D56.9 Thalassaemia, unspecified	0.000	0.998	0.002
C19 Malignant neoplasm of rectosigmoid junction	0.002	0.998	0.000
C77.5 Intrapelvic lymph nodes	0.002	0.998	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.000	0.998	0.002
Q18.0 Sinus, fistula and cyst of branchial cleft	0.000	0.998	0.002
D86.0 Sarcoidosis of lung	0.002	0.998	0.000
F43.2 Adjustment disorders	0.002	0.998	0.000
G61.0 Guillain-Barre syndrome	0.000	0.998	0.002
H59.8 Other postprocedural disorders of eye and adnexa	0.002	0.998	0.000
Y84.8 Other medical procedures	0.000	0.998	0.002
C71.5 Cerebral ventricle	0.002	0.998	0.000
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.002	0.998	0.000
H59.0 Vitreous syndrome following cataract surgery	0.002	0.998	0.000
I71.3 Abdominal aortic aneurysm, ruptured	0.002	0.998	0.000
Q18.1 Preauricular sinus and cyst	0.000	0.998	0.002
U80.1 Methicillin resistant agent	0.002	0.998	0.000
Z01.7 Laboratory examination	0.002	0.998	0.000
C26 Malignant neoplasm of other and ill-defined digestive organs	0.002	0.998	0.000
Q12.0 Congenital cataract	0.000	0.998	0.002
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.002	0.998	0.000
C75 Malignant neoplasm of other endocrine glands and related structures	0.000	0.998	0.002
C25.4 Endocrine pancreas	0.002	0.998	0.000
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.002	0.998	0.000
C77.4 Inguinal and lower limb lymph nodes	0.002	0.998	0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.002	0.998	0.000
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.001	0.998	0.001
C34.0 Main bronchus	0.002	0.998	0.000
C71.4 Occipital lobe	0.002	0.998	0.000
C75.0 Parathyroid gland	0.000	0.998	0.002
C34.3 Lower lobe, bronchus or lung	0.002	0.998	0.000
O86.0 Infection of obstetric surgical wound	0.000	0.998	0.002
H57 Other disorders of eye and adnexa	0.002	0.998	0.000
D56.3 Thalassaemia trait	0.000	0.998	0.002
G61.1 Serum neuropathy	0.000	0.998	0.002
I67.0 Dissection of cerebral arteries, nonruptured	0.002	0.998	0.000
C17.0 Duodenum	0.002	0.998	0.000
C25.8 Overlapping lesion of pancreas	0.002	0.998	0.000
C71.6 Cerebellum	0.002	0.998	0.000
I71.8 Aortic aneurysm of unspecified site, ruptured	0.002	0.998	0.000
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.002	0.998	0.000
C17.8 Overlapping lesion of small intestine	0.002	0.998	0.000
C17.3 Meckel's diverticulum	0.002	0.998	0.000
C24.0 Extrahepatic bile duct	0.002	0.998	0.000
C25.7 Other parts of pancreas	0.002	0.998	0.000
H57.8 Other specified disorders of eye and adnexa	0.002	0.998	0.000
I78.9 Disease of capillaries, unspecified	0.002	0.998	0.000
I78.8 Other diseases of capillaries	0.002	0.998	0.000
X58.9 Unspecified place	0.002	0.998	0.000
H58 Other disorders of eye and adnexa in diseases classified elsewhere	0.002	0.998	0.000
Q18 Other congenital malformations of face and neck	0.000	0.998	0.002
H31.0 Chorioretinal scars	0.000	0.998	0.002
C75.1 Pituitary gland	0.000	0.998	0.002
N99.4 Postprocedural pelvic peritoneal adhesions	0.002	0.998	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.002	0.998	0.000
Y84.1 Kidney dialysis	0.000	0.998	0.002
C71.0 Cerebrum, except lobes and ventricles	0.002	0.998	0.000
V23.9 Unspecified motorcycle rider injured in traffic accident	0.000	0.998	0.002
V23.3 Person injured while boarding or alighting	0.000	0.998	0.002
V23.2 Unspecified motorcycle rider injured in nontraffic accident	0.000	0.998	0.002
V23.1 Passenger injured in nontraffic accident	0.000	0.998	0.002
C74 Malignant neoplasm of adrenal gland	0.000	0.998	0.002
C26.0 Intestinal tract, part unspecified	0.002	0.998	0.000
J37.0 Chronic laryngitis	0.002	0.998	0.000
E06.3 Autoimmune thyroiditis	0.000	0.998	0.002
V23.5 Passenger injured in traffic accident	0.000	0.998	0.002
C71.8 Overlapping lesion of brain	0.002	0.998	0.000
D09.0 Bladder	0.000	0.998	0.002
K08.1 Loss of teeth due to accident, extraction or local periodontal disease	0.002	0.998	0.000
M77.4 Metatarsalgia	0.002	0.998	0.000
C25.3 Pancreatic duct	0.002	0.998	0.000
O86.1 Other infection of genital tract following delivery	0.000	0.998	0.002
C17.9 Small intestine, unspecified	0.002	0.998	0.000
C26.8 Overlapping lesion of digestive system	0.002	0.998	0.000
C26.1 Spleen	0.002	0.998	0.000
V23.0 Driver injured in nontraffic accident	0.000	0.998	0.002
C24.8 Overlapping lesion of biliary tract	0.002	0.998	0.000
C75.8 Pluriglandular involvement, unspecified	0.000	0.998	0.002
C75.4 Carotid body	0.000	0.998	0.002
C75.3 Pineal gland	0.000	0.998	0.002
C75.2 Craniopharyngeal duct	0.000	0.998	0.002
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.002	0.998	0.000
K59.9 Functional intestinal disorder, unspecified	0.000	0.998	0.002
U80 Agent resistant to penicillin and related antibiotics	0.002	0.998	0.000
E11.2 With renal complications	0.000	0.998	0.002
N02.8 Other	0.002	0.998	0.000
O86.8 Other specified puerperal infections	0.000	0.998	0.002
C74.1 Medulla of adrenal gland	0.000	0.998	0.002
I71.0 Dissection of aorta [any part]	0.002	0.998	0.000
C67.3 Anterior wall of bladder	0.000	0.998	0.002
H57.1 Ocular pain	0.002	0.998	0.000
C75.9 Endocrine gland, unspecified	0.000	0.998	0.001
C75.5 Aortic body and other paraganglia	0.000	0.998	0.001
E24.9 Cushing's syndrome, unspecified	0.002	0.998	0.000
F00 Dementia in Alzheimer's disease	0.000	0.998	0.002
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000
K82.8 Other specified diseases of gallbladder	0.002	0.998	0.000
H58.9 Other specified disorders of eye and adnexa in diseases classified elsewhere	0.001	0.998	0.000
H58.1 Visual disturbances in diseases classified elsewhere	0.001	0.998	0.000
H58.0 Anomalies of pupillary function in diseases classified elsewhere	0.001	0.998	0.000
Q18.9 Congenital malformation of face and neck, unspecified	0.000	0.998	0.001
Q18.8 Other specified congenital malformations of face and neck	0.000	0.998	0.001
Q18.7 Microcheilia	0.000	0.998	0.001
Q18.6 Macrocheilia	0.000	0.998	0.001
Q18.5 Microstomia	0.000	0.998	0.001
Q18.4 Macrostomia	0.000	0.998	0.001
Q18.3 Webbing of neck	0.000	0.998	0.001
Q18.2 Other branchial cleft malformations	0.000	0.998	0.001
H57.0 Anomalies of pupillary function	0.002	0.998	0.000
K51.2 Ulcerative (chronic) proctitis	0.002	0.998	0.000
O86 Other puerperal infections	0.000	0.998	0.002
M00.96 Pyogenic arthritis, unspecified (Lower leg)	0.002	0.998	0.000
C24.9 Biliary tract, unspecified	0.001	0.998	0.000
Q12 Congenital lens malformations	0.000	0.998	0.002
V23.99 Motorcycle rider injured in collision with car, pick-up truck or van, Unspecified motorcycle rider injured in traffic accident, Unspecified place	0.000	0.998	0.001
C17.2 Ileum	0.001	0.998	0.000
F00.1 Dementia in Alzheimer's disease with late onset	0.000	0.998	0.001
K08.8 Other specified disorders of teeth and supporting structures	0.002	0.998	0.000
S36.8 Injury of other intra-abdominal organs	0.000	0.998	0.002
C74.0 Cortex of adrenal gland	0.000	0.998	0.001
I71.1 Thoracic aortic aneurysm, ruptured	0.001	0.998	0.000
M00.91 Pyogenic arthritis, unspecified (Shoulder region)	0.001	0.998	0.000
C34.1 Upper lobe, bronchus or lung	0.002	0.998	0.000
G93.2 Benign intracranial hypertension	0.000	0.998	0.002
M77.49 Metatarsalgia-Site unspec	0.001	0.998	0.000
M77.48 Metatarsalgia-Other	0.001	0.998	0.000
M77.46 Metatarsalgia-Lower Leg	0.001	0.998	0.000
M77.45 Metatarsalgia-Pelvic/Thigh	0.001	0.998	0.000
M77.44 Metatarsalgia-Hand	0.001	0.998	0.000
M77.43 Metatarsalgia-Forearm	0.001	0.998	0.000
M77.42 Metatarsalgia-Upper arm	0.001	0.998	0.000
M77.41 Metatarsalgia-Shldr region	0.001	0.998	0.000
M77.40 Metatarsalgia-Mult sites	0.001	0.998	0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.000	0.998	0.001
N32.1 Vesicointestinal fistula	0.000	0.998	0.002
D23.2 Skin of ear and external auricular canal	0.002	0.998	0.000
C74.9 Adrenal gland, unspecified	0.000	0.998	0.001
D10.3 Other and unspecified parts of mouth	0.002	0.998	0.000
Z01.4 Gynaecological examination (general)(routine)	0.001	0.998	0.000
G70 Myasthenia gravis and other myoneural disorders	0.000	0.998	0.001
X63.9 Unspecified place	0.001	0.999	0.000
X63.8 Other specified place	0.001	0.999	0.000
X63.7 Farm	0.001	0.999	0.000
X63.6 Industrial and construction area	0.001	0.999	0.000
X63.5 Trade and service area	0.001	0.999	0.000
X63.4 Street and highway	0.001	0.999	0.000
X63.3 Sports and athletics area	0.001	0.999	0.000
X63.2 School, other institution and public administrative area	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations